CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, has announced a collaboration with Springer Nature to provide mutual customers access to AdisInsight from within CCC’s RightFind Navigate.
Springer Nature’s AdisInsight is an integrated database of reports authored by Springer editors on drugs in development, clinical trials, drug safety, company deals, and patents. AdisInsight expands RightFind Navigate’s growing list of high-value, third-party data sources to include drugs in commercial development, trials to advance drugs through the international regulatory process, safety monitoring including adverse reactions, deals and acquisitions, joint ventures, and collaborations.
Designed to streamline access to a broad spectrum of information and data, RightFind Navigate unifies searching across licensed content sources, publicly available data, and internal proprietary content, empowering researchers to reveal new connections and drive innovation. The solution provides a flexible, scalable, open ecosystem designed to maximize organizations’ returns on their content and data investments.
RightFind Navigate is part of the RightFind Suite, the fastest way to find, manage, and collaborate with content – anytime, anywhere. RightFind was named “Best E-Discovery Solution” by KMWorld in its inaugural Readers’ Choice Awards.
CCC helps companies manage vast amounts of published content and proprietary internal information and data. CCC has established a proven track record of working with a wide range of companies, including content providers and technology partners, to unify data sources and make content more discoverable. The CCC team are experts in processing data from thousands of publishing houses and metadata aggregators accounting for more than 140 million unique records across a diverse set of industries.
Click here to read the original press release.
